Global /South Korea /Healthcare /Biotechnology /041960

Komipharm International Co., Ltd.

041960

• KRX: 041960 • Delayed

9,720KRW -2.1%

6.23 USD

As of 6 June 2026, Komipharm International Co., Ltd. has a market cap of $468.65M USD, ranking #15570 globally and #467 in South Korea. It ranks #1391 in the Healthcare sector, and #268 in the Biotechnology industry.

Global Rank

15570

Country Rank

467

Sector Rank

1391

Industry Rank

268

Key Stats

Market Cap

$468.65MUSD

718.35B KRW

Enterprise Value

$470.31MUSD

733.66B KRW

Revenue (TTM)

$34.23MUSD

52.47B KRW

EBITDA (TTM)

$3.08MUSD

4.8B KRW

Net Income (TTM)

-$4.7MUSD

-7.21B KRW

EBITDA Margin

9.1%

Profit Margin

-14%

PS Ratio

13.7

PB Ratio

10.0

EV/EBITDA

152.9

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

CEO

Seong-Cheol Moon open_in_new

Employees

161

Founded

1972

Website

komipharm.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.1%	6.7%	12%	40%	60%	41%	58%	46%	4.6%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	041960 (주)코미팜 ISIN: KR7041960006 Shares Out.: Shares Outstanding: 71.88M¹ Shares Float: 41.831M² TV: TradingView: KRX: 041960 SA: Stock Analysis: KRX: 041960 YF: Yahoo Finance: 041960.KS GF: Google Finance: KRX: 041960 BA: Barron's: 041960 MS: Morningstar: XKRX: 041960	9,720 KRW	TV: TradingView: KRX: 041960 SA: Stock Analysis: KRX: 041960 YF: Yahoo Finance: 041960.KS GF: Google Finance: KRX: 041960 BA: Barron's: 041960 MS: Morningstar: XKRX: 041960

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Komipharm International Co., Ltd.

Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. The company manufactures veterinary drugs in injectable, powder, oral solution, topical solution, disinfectant, and other forms. It also develops anticancer drugs and cancer pain-relieving agents for human health and life. In addition, the company engages in clinical pathological experiment, test, and analysis activities. The company was formerly known as Korea Microbiological Laboratories Co., Ltd. and changed its name to Komipharm International Co., Ltd. in September 2004. The company was founded in 1972 and is headquartered in Siheung-Si, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 9K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$27.89B 42.76T KRW 6K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.27B 20.33T KRW 3K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.46B 8.37T KRW 1K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.96B 6.07T KRW 746%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.23B 3.42T KRW 377%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 39K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 34K%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 10K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 9K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 9K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 6K%	-	United States

chevron_leftBack